Answers are grounded in this paper and cite their sources.
Case report demonstrates suppression of persistent ventricular tachycardia in a male patient in his 60s, suggesting the therapeutic utility of stellate ganglion ablation.
This case report presents the effectiveness of stellate ganglion ablation for the control of persistent ventricular tachycardia (VT) resistant to standard therapies. A male patient in his 60s with a history of ischemic cardiomyopathy, implanted cardioverter-defibrillator (ICD), and recent coronary angioplasty experienced multiple daily recurrent VT episodes. Runs of low-rate VT episodes persisted despite extensive medical and interventional efforts. Unlike previous procedures, blockade of stellate ganglion and consequent thoracoscopic stellate ganglion ablation resulted in complete suppression of arrhythmia. The report highlights the promising outcomes of a holistic approach involving explorative percutaneous stellate ganglion blockade and consequent ablation of stellate ganglion for sympathetic denervation, offering potential improvement in challenging clinical scenarios.
No takes yet. Share an insight, caveat, or question.
Laureckas et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: